| Literature DB >> 2180331 |
D A Scott1, R L Haberberger, S A Thornton, K C Hyams.
Abstract
Norfloxacin, an oral fluoroquinolone (dose 400 mg daily), was compared to a placebo in a double blinded randomized trial for the prophylaxis of travelers' diarrhea. The study was of U.S. Navy and Marine Corps personnel on shore leave in Alexandria, Egypt. A total of 222 subjects were available (105 norfloxacin, 117 placebo). In the placebo group, 26% (30/117) developed acute diarrhea vs. 2% (2/105) in the norfloxacin group. There were no significant side effects in either group.Entities:
Mesh：
Substances：
Year: 1990 PMID： 2180331 DOI： 10.4269/ajtmh.1990.42.160
Source DB: PubMed Journal: Am J Trop Med Hyg ISSN： 0002-9637 Impact factor: 2.345